Immediate Impact

1 by Nobel laureates 52 standout
Sub-graph 1 of 24

Citing Papers

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
2 intermediate papers

Works of C. Sessa being referenced

Corrections to “Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”
2018
Results from a phase 1/2 study of volociximab in combination with liposomal doxorubicin in relapsed advanced epithelial ovarian and primary peritoneal carcinoma
2008

Author Peers

Author Last Decade Papers Cites
C. Sessa 199 118 91 104 24 436
Rocco De Vivo 162 77 164 104 24 413
Sze Chai Chan 115 98 89 69 31 423
Gaetano Saggio 208 94 67 82 28 456
Hakan Karagöl 167 51 154 126 34 467
Katrin Hefler‐Frischmuth 202 29 116 71 17 470
Despina Mouratidou 222 81 114 160 21 429
W. Mattsson 269 73 75 74 29 470
Roberto Valenza 288 40 154 120 41 461
A Bataillard 162 29 124 63 30 383
Hyun Jeong Shim 138 145 107 172 30 468

All Works

Loading papers...

Rankless by CCL
2026